JP5879356B2 - ペプチド - Google Patents

ペプチド Download PDF

Info

Publication number
JP5879356B2
JP5879356B2 JP2013535500A JP2013535500A JP5879356B2 JP 5879356 B2 JP5879356 B2 JP 5879356B2 JP 2013535500 A JP2013535500 A JP 2013535500A JP 2013535500 A JP2013535500 A JP 2013535500A JP 5879356 B2 JP5879356 B2 JP 5879356B2
Authority
JP
Japan
Prior art keywords
sequence
peptide
fty
fsy
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013535500A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014500245A (ja
JP2014500245A5 (https=
Inventor
ジャラン ラウオ，
ジャラン ラウオ，
Original Assignee
マレアリス エイエス
マレアリス エイエス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マレアリス エイエス, マレアリス エイエス filed Critical マレアリス エイエス
Publication of JP2014500245A publication Critical patent/JP2014500245A/ja
Publication of JP2014500245A5 publication Critical patent/JP2014500245A5/ja
Application granted granted Critical
Publication of JP5879356B2 publication Critical patent/JP5879356B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013535500A 2010-10-26 2011-07-13 ペプチド Active JP5879356B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1018125.3A GB201018125D0 (en) 2010-10-26 2010-10-26 Peptide
GB1018125.3 2010-10-26
PCT/GB2011/051314 WO2012056205A1 (en) 2010-10-26 2011-07-13 Peptide

Publications (3)

Publication Number Publication Date
JP2014500245A JP2014500245A (ja) 2014-01-09
JP2014500245A5 JP2014500245A5 (https=) 2014-08-14
JP5879356B2 true JP5879356B2 (ja) 2016-03-08

Family

ID=43365585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013535500A Active JP5879356B2 (ja) 2010-10-26 2011-07-13 ペプチド

Country Status (11)

Country Link
US (2) US9044511B2 (https=)
EP (1) EP2632937B8 (https=)
JP (1) JP5879356B2 (https=)
CN (1) CN103249741B (https=)
AU (1) AU2011322287B2 (https=)
BR (1) BR112013009679B1 (https=)
CA (1) CA2856153C (https=)
DK (1) DK2632937T3 (https=)
GB (1) GB201018125D0 (https=)
RU (1) RU2572623C2 (https=)
WO (1) WO2012056205A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107337711A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Pro‑Hyp及应用和药物组合物
CN107325153A (zh) * 2017-07-26 2017-11-07 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Hyp‑Pro及应用和药物组合物
JPWO2021059840A1 (ja) * 2019-09-27 2021-10-07 太陽化学株式会社 アンジオテンシン変換酵素阻害剤
TWI890506B (zh) * 2024-06-27 2025-07-11 開曼群島商味丹國際（控股）有限公司 具有抑制ace活性之胜肽及其組合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455303A (en) * 1983-05-24 1984-06-19 The General Hospital Corporation Renin inhibitors
US5545719A (en) 1990-05-01 1996-08-13 Neuromedica, Inc. Nerve growth peptides
RU2084458C1 (ru) * 1993-05-27 1997-07-20 Институт высокомолекулярных соединений РАН Декапептид, обладающий противоопухолевой активностью
JP4879020B2 (ja) * 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
WO2005007090A2 (en) * 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
AU2003253301A1 (en) 2003-07-31 2004-07-14 Franco Felici Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response
AT502292B1 (de) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
HUP0600814A3 (en) * 2006-10-27 2009-08-28 Biostatin Gyogyszerkutato Fejl Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
CN101092450A (zh) * 2007-01-10 2007-12-26 中国人民解放军第三军医大学第一附属医院 与人mhc－ⅰ类分子结合的肝素酶多肽表位
EP3103467A1 (en) * 2008-02-07 2016-12-14 Cornell University Methods for preventing or treating insulin resistance
FR2943346B1 (fr) 2009-03-19 2011-05-06 Univ Paris Curie Peptides modulant l'activite de l'igf-1 et leurs applications
GB201008462D0 (en) 2010-05-20 2010-07-07 Marealis As Process

Also Published As

Publication number Publication date
CN103249741A (zh) 2013-08-14
US20130281358A1 (en) 2013-10-24
CN103249741B (zh) 2015-12-02
BR112013009679A2 (pt) 2016-07-12
WO2012056205A1 (en) 2012-05-03
RU2572623C2 (ru) 2016-01-20
JP2014500245A (ja) 2014-01-09
EP2632937A1 (en) 2013-09-04
CA2856153C (en) 2019-04-16
RU2013124991A (ru) 2014-12-10
AU2011322287A1 (en) 2013-05-02
EP2632937B1 (en) 2016-03-16
GB201018125D0 (en) 2010-12-08
AU2011322287B2 (en) 2015-06-25
CA2856153A1 (en) 2012-05-03
EP2632937B8 (en) 2016-06-22
US9044511B2 (en) 2015-06-02
BR112013009679B1 (pt) 2020-12-01
DK2632937T3 (en) 2016-05-30
US20150315236A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
Yu et al. Antihypertensive effect of angiotensin-converting enzyme inhibitory peptide RVPSL on spontaneously hypertensive rats by regulating gene expression of the Renin–Angiotensin System
Saleh et al. Recent research in antihypertensive activity of food protein-derived hydrolyzates and peptides
EP2420244B1 (en) Lipid metabolism-improving agent
US10308681B2 (en) Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
CN104159912B (zh) 二肽基肽酶iv 抑制剂
JP6189994B2 (ja) ジペプチジルペプチダーゼ−ｉｖ阻害用飲食品組成物
CN101889083A (zh) 菠萝蛋白酶的选定组分的重组制备
JP5715117B2 (ja) 摂食障害治療剤
JP5976004B2 (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP5879356B2 (ja) ペプチド
JP2015084694A (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
WO2023192711A1 (en) Compositions and methods for delivering bioactive agents
JP2013184962A (ja) ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP5980519B2 (ja) Ａｍｐｋ活性化剤
JP2004099447A (ja) コレステロール低減化ペプチド
KR101404850B1 (ko) 클로렐라 유래 항고혈압 활성을 갖는 펩티드
JP2019533988A (ja) Ｐｋｕ治療のためのフェニルアラニン非含有タンパク質
WO2014030977A1 (ko) 안지오텐신-i 전환 효소 저해능을 나타내는 펩타이드를 유효성분으로 포함하는 심혈관계 질환 예방 또는 치료용 약학적 조성물
JP5430803B2 (ja) ペプチドおよびアンジオテンシン変換酵素阻害剤
WO2017085270A1 (en) Antihypertensive peptides from olive oil

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140625

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150826

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160119

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160201

R150 Certificate of patent or registration of utility model

Ref document number: 5879356

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250